Xerion Healthcare Ltd. logo

Xerion Healthcare Ltd.

Xerion Healthcare develop nanoparticles that are used to improve treatment of cancer. The nanoparticles are injected into tumours just prior to standard radiotherapy and act to enhance the effectiveness of the treatment, amplifying the dose of free radicals generated by the X-rays. The nanoparticles are based on titanium dioxide, a common, non-toxic, semiconductor material.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.xerionhealthcare.co.uk
Disease Focus
Development Stage
STOCK CODENon Listed
Address
30 Upper High Street, OX9 3EZ
Thame
United Kingdom
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/xerion-healthcare-limited” connections=”true” suffix=””]